
Health Tidings
Manufacturing
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Manufacturing
ManufacturingFujifilm, Taiho Partner to Advance Manufacturing of Next-Gen ADCsFUJIFILM Corporation and Taiho Pharmaceutical have formed a strategic partnership to optimize manufacturing technologies for next-generation antibody-drug conjugates using the AraLinQ platform, strengthening global ADC production capabilities.Fact-Checked
ManufacturingGates MRI Taps GSK’s AS01E Adjuvant and Serum Institute of India’s Manufacturing Scale to Advance M72/AS01E TB Vaccine ProgramThe Gates Medical Research Institute has selected Serum Institute of India as the manufacturing partner for M72/AS01E, an investigational tuberculosis vaccine currently in Phase 3 testing.Fact-Checked
ManufacturingMHRA Approves UK Plasma Manufacturing for Five High-Priority MedicinesThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has lifted long‑standing restrictions on UK‑sourced plasma, authorizing its use in manufacturing five high‑priority plasma‑derived medicinal products.Fact-Checked
ManufacturingMacroGenics Hands Bora the Keys to Its Maryland Manufacturing EngineBora Pharmaceuticals will acquire MacroGenics’ GMP manufacturing operations for $122.5 million, adding an FDA-approved biologics facility in Maryland and expanding its North American CDMO capabilities.Fact-Checked
ManufacturingSerum Institute Starts Development of Meiji’s Japanese Encephalitis Vaccine in IndiaKM Biologics Co., Ltd. and Serum Institute of India Private Limited initiate development of a Japanese encephalitis vaccine in India after achieving the first milestone under a technology…Fact-Checked
ManufacturingAREXVY Gains FDA Approval for Ready-to-Use Vial and Prefilled SyringeFDA has approved a new vial–prefilled syringe presentation for AREXVY, enabling more streamlined vaccine preparation while supporting expanded manufacturing and supply.Fact-Checked
ManufacturingMHRA Recalls Napralief Painkiller Over Missing Safety InformationSpecific batches of Napralief 250 mg tablets are being recalled as a precaution after regulators identified missing dosage instructions and key safety warnings in product information, potentially affecting…Fact-Checked
ManufacturingAskBio Scales Up Production of Ametefgene Parvec to Support Ongoing Phase II StudyAskBio has enabled large-scale production of ametefgene parvec to support ongoing Phase II clinical development in Parkinson’s disease, marking a key operational step in advancing its gene therapy…Fact-Checked
ManufacturingGSK Ends Wellcovorin Era as FDA Withdraws Leucovorin NDA After DiscontinuationThe FDA has withdrawn approval of GSK’s Wellcovorin (leucovorin calcium) tablets after the company confirmed the product is no longer marketed and requested withdrawal.Fact-Checked
ManufacturingFDA Issues Warning Letter Over Illegal Online Sale of Unapproved GLP-1 Weight Loss DrugThe U.S. Food and Drug Administration issued a warning letter over the online sale of an unapproved GLP-1 weight loss product, stating the drug is marketed with claims…Fact-Checked
ManufacturingIonis Cuts TRYNGOLZA Price Ahead of Potential sHTG ApprovalIonis Pharmaceuticals has lowered the annual WAC of TRYNGOLZA (olezarsen) to $40,000, a move aimed at improving patient access and preparing for a potential FDA approval in severe…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.